Financial burden for tuberculosis patients in low- and middle-income countries: a systematic review
Open accessThe DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
In order to inform the development of appropriate strategies to improve financial risk protection, we conducted a systematic literature review of the financial burden of tuberculosis (TB) faced by patients and affected families. The mean total costs ranged from $55 to $8198, with an unweighted average of $847. On average, 20% (range 0–62%) of the total cost was due to direct medical costs, 20% (0–84%) to direct non-medical costs, and 60% (16–94%) to income loss. Half of the total cost was incurred before TB treatment. On average, the total cost was equivalent to 58% (range 5–306%) of reported annual individual and 39% (4–148%) of reported household income. Cost as percentage of income was particularly high among poor people and those with multidrug-resistant TB. Commonly reported coping mechanisms included taking a loan and selling household items. The total cost of TB for patients can be catastrophic. Income loss often constitutes the largest financial risk for patients. Apart from ensuring that healthcare services are fairly financed and delivered in a way that minimises direct and indirect costs, there is a need to ensure that TB patients and affected families receive appropriate income replacement and other social protection interventions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
International Labour Organization
(2022) · Permanent Missions to the United Nations · doi:10.18356/9789210018289c229 · Cited by 4,331
Health systems financing and the path to universal coverage
Evans, D. B., & Etienne, C. (2010) · Bulletin of the World Health Organization · doi:10.2471/blt.10.078741 · Cited by 1,279
Drivers of tuberculosis epidemics: The role of risk factors and social determinants
Lönnroth, K., Jaramillo, E., Williams, B. G., Dye, C., & Raviglione, M. (2009) · Social Science & Medicine · doi:10.1016/j.socscimed.2009.03.041 · Cited by 1,176
Self-citationTuberculosis control and elimination 2010–50: cure, care, and social development
Lönnroth, K., Castro, K. G., Chakaya, J. M., Chauhan, L. S., Floyd, K., Glaziou, P., & Raviglione, M. C. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60483-7 · Cited by 899
Self-citationThe Social Determinants of Tuberculosis: From Evidence to Action
Hargreaves, J. R., Boccia, D., Evans, C. A., Adato, M., Petticrew, M., & Porter, J. D. H. (2011) · American Journal of Public Health · doi:10.2105/ajph.2010.199505 · Cited by 625
Bates, I., Fenton, C., Gruber, J., Lalloo, D., Lara, A. M., Squire, S. B., Theobald, S., Thomson, R., & Tolhurst, R. (2004) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(04)01002-3 · Cited by 267
Socio-economic impact of tuberculosis on patients and family in India.
Rajeswari, R., Balasubramanian, R., Muniyandi, M., Geetharamani, S., Thresa, X., & Venkatesan, P. (1999) · PubMed · Cited by 244
Barter, D. M., Agboola, S. O., Murray, M. B., & Bärnighausen, T. (2012) · BMC Public Health · doi:10.1186/1471-2458-12-980 · Cited by 199
Fitzpatrick, C., & Floyd, K. (2012) · PharmacoEconomics · doi:10.2165/11595340-000000000-00000 · Cited by 186
Kemp, J. (2007) · Bulletin of the World Health Organization · doi:10.2471/blt.06.033167 · Cited by 126
Cost and cost-effectiveness of PPM-DOTS for tuberculosis control: evidence from India
Floyd, K., Arora, V. K., Murthy, K. J. R., Lönnroth, K., Singla, N., Akbar, Y. H., Zignol, M., & Uplekar, M. W. (2006) · Bulletin of the World Health Organization · doi:10.2471/blt.05.024109 · Cited by 122
Self-citationMauch, V., Bonsu, F. A., Gyapong, M., Awini, E., Suarez, P. G., Marcelino, B., Melgen, R. E., Lönnroth, K., Nhung, N. V., Hoa, N. B., et al. (2013) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.12.0368 · Cited by 122
Self-citationEconomic impact of tuberculosis at the household level.
Kamolratanakul, P., Sawert, H., Kongsin, S., et al. (1999) · PubMed · Cited by 112
Khan, M. (2002) · Health Policy and Planning · doi:10.1093/heapol/17.2.178 · Cited by 110
Cost and cost-effectiveness of community-based care for tuberculosis in Cape Town, South Africa.
Sinanovic, E., Floyd, K., Dudley, L., Azevedo, V. D. S., Grant, R., & Maher, D. (2003) · PubMed · Cited by 95
Lönnroth, K., Aung, T. T., Maung, W., Kluge, H. H. P., & Uplekar, M. (2007) · Health Policy and Planning · doi:10.1093/heapol/czm007 · Cited by 94
Self-citationLong, Q., Smith, H. J. J., Zhang, T., Tang, S., & Garner, P. (2011) · BMC Public Health · doi:10.1186/1471-2458-11-393 · Cited by 94
Cost of tuberculosis diagnosis and treatment from the patient perspective in Lusaka, Zambia.
Aspler, A., Menzies, D., Oxlade, O., Banda, J., Mwenge, L., Godfrey‐Faussett, P., & Ayles, H. (2008) · PubMed · Cited by 89
Ukwaja, K. N., Modebe, O., Igwenyi, C., & Alobu, I. (2012) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.11.0193 · Cited by 88
Datiko, D. G., & Lindtjørn, B. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009158 · Cited by 74
Costs of tuberculosis for households and health care providers in Dar es Salaam, Tanzania
Wyss, K., Kilima, P. M., & Lorenz, N. (2001) · Tropical Medicine & International Health · doi:10.1046/j.1365-3156.2001.00677.x · Cited by 73
Cost and cost-effectiveness of community-based care for tuberculosis patients in rural Uganda.
Okello, D., Floyd, K., Adatu, F., Odeke, R., & Gargioni, G. (2003) · PubMed · Cited by 68
An economic evaluation of alternative programme designs for tuberculosis control in rural Uganda
Saunderson, P. R. (1995) · Social Science & Medicine · doi:10.1016/0277-9536(94)00240-t · Cited by 67
Health Equity and Financial Protection: Streamlined Analysis with ADePT Software
Bilger, M., Wagstaff, A. R., Sajaia, Z., & Lokshin, M. M. (2011) · World Bank, Washington, DC eBooks · doi:10.1596/978-0-8213-8459-6 · Cited by 59
Meng, Q., Li, R., Cheng, G., & Blas, E. (2004) · The International Journal of Health Planning and Management · doi:10.1002/hpm.774 · Cited by 59
Liu, X., Thomson, R., Gong, Y., Zhao, F., Squire, S. B., Tolhurst, R., Zhao, X., Yan, F., & Tang, S. (2007) · Tropical Medicine & International Health · doi:10.1111/j.1365-3156.2007.01953.x · Cited by 53
Wandwalo, E. R., Robberstad, B., & Mørkve, O. (2005) · Cost Effectiveness and Resource Allocation · doi:10.1186/1478-7547-3-6 · Cited by 52
Pantoja, A. F., Lönnroth, K., Lal, S., Chauhan, L. S., Uplekar, M., Padma, M. R., Unnikrishnan, K. P., Jammy, G. R., Kumar, P. R., Sahu, S., et al. (2009) · PubMed · Cited by 48
Self-citationPatients Are Paying Too Much for Tuberculosis: A Direct Cost-Burden Evaluation in Burkina Faso
Laokri, S., Drabo, M., Weil, O., Kafando, B., Dembélé, S. M., & Dujardin, B. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056752 · Cited by 46
Revenue-driven in TB control?three cases in China
Zhan, S., Wang, L., Yin, A., & Blas, E. (2004) · The International Journal of Health Planning and Management · doi:10.1002/hpm.778 · Cited by 43
do Prado, T. N., Wada, N., Guidoni, L. M., Golub, J. E., Dietze, R., & Maciel, E. L. N. (2011) · Cadernos de Saúde Pública · doi:10.1590/s0102-311x2011000500012 · Cited by 41
Costs of a successful public-private partnership for TB control in an urban setting in Nepal
Karki, D. K., Mirzoev, T. N., Green, A. T., Newell, J. N., & Baral, S. (2007) · BMC Public Health · doi:10.1186/1471-2458-7-84 · Cited by 29
Community-based DOTS and family member DOTS for TB control in Nepal: costs and cost-effectiveness
Mirzoev, T. N., Baral, S., Karki, D. K., Green, A. T., & Newell, J. N. (2008) · Cost Effectiveness and Resource Allocation · doi:10.1186/1478-7547-6-20 · Cited by 19
Economic burden of tuberculosis in patients attending DOT centres in Delhi.
Ray, T. K., Sharma, N., Singh, M., & Ingle, G. (2005) · PubMed · Cited by 17
(2002) · Europe PMC (PubMed Central)
Cited by
A 24-Week, All-Oral Regimen for Rifampin-Resistant Tuberculosis
Nyang’wa, B.-T., Berry, C., Kazounis, E., Motta, I., Parpieva, N., Tigay, Z., Solodovnikova, V., Liverko, I., Moodliar, R., Dodd, M., et al. (2022) · New England Journal of Medicine · doi:10.1056/nejmoa2117166 · Cited by 376
Building a tuberculosis-free world: The Lancet Commission on tuberculosis
Reid, M. J. A., Arinaminpathy, N., Bloom, A., Bloom, B. R., Boehme, C., Chaisson, R., Chin, D. P., Churchyard, G., Cox, H., Ditiu, L., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)30024-8 · Cited by 361
Self-citationTuberculosis, social determinants and co-morbidities (including HIV)
Duarte, R., Lönnroth, K., Carvalho, C., Lima, F., Carvalho, A. C. C., Muñoz-Torrico, M., & Centis, R. (2018) · Pulmonology · doi:10.1016/j.rppnen.2017.11.003 · Cited by 324
Self-citationMirzayev, F., Viney, K., Linh, N. N., Gonzalez-Angulo, L., Gegia, M., Jaramillo, E., Zignol, M., & Kasaeva, T. (2021) · European Respiratory Journal · doi:10.1183/13993003.03300-2020 · Cited by 301
Self-citationRomanowski, K., Baumann, B., Basham, C. A., Ahmad Khan, F., Fox, G. J., & Johnston, J. C. (2019) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(19)30309-3 · Cited by 288
Metadata
- Authors
- Tanimura, T., Jaramillo, E., Weil, D., Raviglione, M., & Lönnroth, K.
- Venue
- European Respiratory Journal
- Publisher
- European Respiratory Society (ERS)
- Published
- 2014-02-13
- Volume
- 43
- Issue
- 6
- Pages
- 1763-1775
- ISSN
- 0903-1936 (ISSN-L)
- 1399-3003
- OpenAlex
- W2107112569
- Cited by
- 586
- References
- 35
- FWCI
- 19.91
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.